EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome Editing in Mouse Embryo Using the CRISPR/Cas12i3 System

Jiale He, Juan Liu, Yuan Yue, Lin Wang, Zhize Liu, Guangyin Xi, Lei An, Jianhui Tian, Yinjuan Wang

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26073036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Jiale He und 8 weiteren Autor:innen. Beteiligte Einrichtung: Frontiers Science Center for Molecular Design Breeding (MOE), Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agricul…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Gene Editing, Embryo, Mammalian. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Chinese Universities Scientific Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The CRISPR/Cas system is a sizable family that is currently a popular and efficient gene editing tool. Cas12i3, as a member of the Type V-I family, has the characteristics of recognizing T-rich PAM sequences and being guided by shorter crRNA and has higher gene editing efficiency than Cas9 in rice. However, as a potential tool in accelerating the breeding process, the application of Cas12i3 in mammalian embryos has not yet been reported. Our study systematically evaluated the feasibility of applying CRISPR/Cas12i3 to gene editing in mouse embryos, with the core pluripotency regulator gene Nanog as the target. We successfully constructed a Nanog loss-of-function mouse embryo model using CRISPR/Cas12i3. At the targeted Nanog locus, its editing efficiency exceeded that of the Cas9 system under matched experimental conditions; no off-target phenomenon was detected. Moreover, the Cas12i3 system exhibited no side effect on mouse embryo development and proliferation of blastocyst cells. Finally, we obtained healthy chimeric gene-edited offspring by optimizing the concentration of the Cas12i3 mixture. These results confirm the feasibility and safety of CRISPR/Cas12i3 for gene editing in mammals, which provides a reliable tool for one-step generation of gene-edited animals for applications in biology, medical research, and large livestock breeding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGene EditingEmbryo, MammalianAnimalsMiceNanog Homeobox ProteinFemaleEmbryonic DevelopmentBlastocyst

Stichwörter der Autor:innen

CRISPR/Cas12i3Nanoggenome editingmouse embryo

Substanzen

Nanog Homeobox ProteinNanog protein, mouse

Autor:innen und Institutionen

  • Frontiers Science Center for Molecular Design Breeding (MOE), Key Laboratory of Animal Genetics, Breeding and Reproduction of the Ministry of Agriculture and Rural Affairs, National Engineering Laboratory for Animal Bre…

Förderung

  • National Key R&D Program of China
  • Chinese Universities Scientific Fund

Zitieren

APA

He, J., Liu, J., Yue, Y., Wang, L., Liu, Z., Xi, G., An, L., Tian, J., & Wang, Y. (2025). Genome Editing in Mouse Embryo Using the CRISPR/Cas12i3 System. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26073036

Vancouver

He J, Liu J, Yue Y, Wang L, Liu Z, Xi G, et al. Genome Editing in Mouse Embryo Using the CRISPR/Cas12i3 System. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26073036

BibTeX
@article{He2025,
  author = {He, Jiale and Liu, Juan and Yue, Yuan and Wang, Lin and Liu, Zhize and Xi, Guangyin and An, Lei and Tian, Jianhui and Wang, Yinjuan},
  title = {Genome Editing in Mouse Embryo Using the CRISPR/Cas12i3 System},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26073036}
}
Kostenlos starten →